Clinical Trials · NCT05922579

A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (NET) and Nurses Involved in the Care of Patients With NET

Name: A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (NET) and Nurses Involved in the Care of Patients With NET
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

TerminatedN/ALanreotide

Phase: N/A
Recruitment status: Terminated
Sponsor: Ipsen
Enrollment: 191
Start date: Jun 2023
Locations: 1 site, Australia
Primary endpoint: Attribute importance

View Lanreotide compound reference